Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

PLEXR PLUS

K-Number: K210693 · 2022-03-22

ApplicantGmv S.R.L.
Decision Date2022-03-22
Product CodeGEI
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

PLEXR PLUS is the device name listed in this FDA 510(k) record. The listed applicant is Gmv S.R.L.. It received FDA 510(k) clearance on 2022-03-22 under 510(k) number K210693. The device is classified under product code GEI. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the PLEXR PLUS?

PLEXR PLUS is a medical device that received FDA 510(k) clearance on 2022-03-22. The listed applicant is Gmv S.R.L.. The 510(k) number is K210693.

When did PLEXR PLUS receive FDA 510(k) clearance?

PLEXR PLUS received FDA 510(k) clearance on 2022-03-22, under 510(k) number K210693.

Who is the listed applicant for PLEXR PLUS?

The FDA 510(k) record lists Gmv S.R.L. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for PLEXR PLUS?

The FDA product code for PLEXR PLUS is GEI.

Related Devices (Code: GEI)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.